Scalability

Digital products for biotech and diagnostics. portals, platforms, AI tools and growth. NYC-based, working globally.

[Scalability @scalability_us]

rocket running vantagescore 4.0 beside classic fico for conventional and va loans is how regulated products actually modernize. parallel first, trust later, replacement last. boring is the safest way to ship.

[Scalability @scalability_us]

gsa pushing ai procurement toward fixed-price models is a very useful reality check. the public sector will not buy the best demo. it will buy the team that understands scope, risk and acquisition mechanics.

[Scalability @scalability_us]

servier's edgewise deal could reach nearly $2.7b, with $1.55b upfront.

biotech buyers pay for science first. but the platform story still matters: clean data, trial visibility and operational credibility make diligence easier.

[Scalability @scalability_us]

the average enterprise went from 130 saas apps in 2022 to 106 now. that is not the end of software. it is the end of tools that sit alone. the next useful ai agent has to cross systems, not add another tab.

[Scalability @scalability_us]

healthcare ai keeps getting framed as an adoption problem. invoca says 58% of healthcare orgs are held back by legacy infrastructure. so the work is less “add ai” and more boring: fix the workflows, data paths and handoffs the model depends on.

[Scalability @scalability_us]

fhir gives everyone a common language. it still does not make prior auth, referrals and digital front doors work. healthcare it news nailed the real problem: scale breaks at the handoff between the standard and the operating model.

[Scalability @scalability_us]

govtech ai will be won in procurement, not demo day. glass and sourcewell just launched an ai marketplace around pre-awarded contracts. that is the part vendors skip: if agencies cannot buy it cleanly, model quality barely matters.

[Scalability @scalability_us]

the ai agent businesses that print money look boring from the outside. avoca raised $125m at a $1b valuation by handling inbound calls, booking, estimates and follow-ups for home services. pain you can count beats a beautiful demo.

[Scalability @scalability_us]

consumer biotech is turning into an ops problem. if value moves to the distribution layer, portals, clinical workflows, fulfillment and compliance become the moat. the biology can be brilliant and still lose at the handoff.

[Scalability @scalability_us]

ihh runs 190 healthcare facilities and says nurse rostering + revenue cycle ai saved up to 800,000 hours a year. that is why back-office ai moves faster than clinical ai. lower trust barrier, clearer roi, less regulatory drama.

[Scalability @scalability_us]

a complex patient chart review used to take an hour or more at choc. now they say it can be managed in minutes, with annotations back to source docs. that is the useful version of healthcare ai: less hunting, better judgment, clinician still in charge.

[Scalability @scalability_us]

innovaccer didn't buy caduceushealth for a chatbot. it bought almost 30 years of rcm ops, 4,000 practices, and $5b in annual gross patient charges. boring workflows are where ai gets paid first.

[Scalability @scalability_us]

most real estate ai is still built for one agent at a time. housingwire profiled roro doing brokerage-level mls intelligence: pricing, timing, micro-trends, live queries. fewer solo toys, more shared operating memory.

[Scalability @scalability_us]

workday pushing sana into itsm after hr and finance is the enterprise ai tell. once agents touch approvals, budgets and permissions, the product problem stops being chat. it becomes trust architecture.

[Scalability @scalability_us]

microsoft and ey putting $1b behind ai adoption over five years is the tell. enterprise ai doesn't fail because the model is too dumb. it fails because nobody translates the tech into workflows, governance and outcomes.

[Scalability @scalability_us]

mayo + stanford are using ai on blood biopsies to read tumor microenvironments. current tumor genomics only supports decisions for about 5% of patients. the model is cool. the workflow around it decides if it changes care.

[Scalability @scalability_us]

dhs wants ai biosurveillance across transportation, border, supply chain and agriculture data ahead of the world cup, america250 and 2028 olympics. federal ai demand is becoming messy integration work. good. that's the real work.

[Scalability @scalability_us]

remax select grew transaction sides 67% from 2021 to 2025, hitting 7,005 sides. leadership credited collaboration and internal referrals. real estate tech should make the operating network stronger, not give agents another dashboard to ignore.

[Scalability @scalability_us]

we set up a per-client ai system that scores 200+ leads daily. what used to take a human 4 hours now runs while you sleep. the catch? it's not magic. it's understanding exactly where people drop off.

[Scalability @scalability_us]

lims integration is where most diagnostic platforms break. not because the data is hard to move. because compliance requirements force you to trace every data point back to its source. most vendors just pipe it through.